Phase 1 Clinical Trial of a Novel HER2 Vaccine for Patients with DCIS

Medicine & Life Sciences

1. Aromatase Inhibitors 8%
2. Breast Cancer 3 9%
3. Breast Neoplasms 34%
4. Carcinoma, Intraductal, Noninfiltrating 100%
5. Clinical Trials, Phase I 59%
6. Costs and Cost Analysis 8%
7. Disease Progression 5%
8. Drug Therapy 7%
9. Endometrial Neoplasms 6%
10. Estrogen Antagonists 10%
11. Estrogen Receptors 6%
12. Extranodal Extension 9%
13. Health 9%
14. Immune System 5%
15. Immunity 16%
16. Immunization 17%
17. Incidence 9%
18. Mastectomy 7%
19. Neoplasms 13%
20. Oncogene Proteins 7%
21. Poisons 5%
22. Preliminary Data 7%
23. Radiation 5%
24. Research Ethics Committees 7%
25. Risk Management 7%
26. Segmental Mastectomy 7%
27. Tamoxifen 14%
28. Thrombosis 5%
29. United States Food and Drug Administration 6%
30. Uterine Cervical Neoplasms 6%
31. Uterine Neoplasms 8%
32. Vaccination 5%
33. Vaccines 51%
34. Weight Gain 6%